Peptide
Tesamorelin
Visceral fat's nemesis
A synthetic form of growth hormone-releasing hormone approved for reducing excess abdominal fat. It specifically targets visceral adipose tissue while preserving muscle.
Mechanisms
- GHRH receptor activation
- Visceral fat reduction
- IGF-1 elevation
- Hepatic fat reduction
Dosing
Typical dose
1–2mg
Timing
Daily subcutaneous injection. Best results seen after 3+ months of consistent use.